Trial intelligence / Profile preview

Capsaicin for Post-stroke Dysphagia

NCT04470752Phase 2Unknown

Start
Aug 2021
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Cauterex in dysphagia. Status: unknown.

02

Drugs

Cauterex
03

Conditions

dysphagia

Beyond the preview

Go deeper on NCT04470752.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04470752.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call